CIK 0000093314
- Non-accelerated filer
- Smaller reporting company
VOLITIONRX LTD
Sign in to watch- Ticker
- VNRX
- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 911949078
- Phone
- +1 512-774-8930
- Business address
- 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV, 89014
- Former names
- VOLITIONRX LTD, STANDARD CAPITAL CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-01 | Rootsaert Rodney Gerard Secretary | Grant or award | +10,190 | 147,763 | ||
| 2025-06-01 | Rootsaert Rodney Gerard Secretary | Shares withheld for taxes | −6,408 | $0.50 | $3K | 141,355 |
| 2025-06-01 | Forterre Gael Chief Commercial Officer | Grant or award | +6,690 | 165,696 | ||
| 2025-06-01 | Forterre Gael Chief Commercial Officer | Shares withheld for taxes | −4,234 | $0.50 | $2K | 161,462 |
| 2025-06-01 | Retter Andrew Chief Medical Officer | Grant or award | +13,069 | 146,773 | ||
| 2025-06-01 | Retter Andrew Chief Medical Officer | Shares withheld for taxes | −4,598 | $0.50 | $2K | 142,175 |
| 2025-06-01 | Hughes Terig Chief Financial Officer | Grant or award | +17,406 | 407,627 |
Page 6 of 6 · 107 trades